Lexaria Bioscience Corp (LEXXW) — Capital Reinvestment Ratio

Latest as of November 2013: 0.37x

Lexaria Bioscience Corp (LEXXW) has a Capital Reinvestment Ratio of 0.37x as of November 2013, meaning it reinvests 0% of its operating cash flow ($74.27K) in capital expenditures ($27.23K). See Lexaria Bioscience Corp balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.37x
Capex / Operating Cash Flow

Operating Cash Flow

$74.27K
USD

Capital Expenditures

$27.23K
USD

Data as of

Nov 2013
Most recent filing

Lexaria Bioscience Corp Capital Reinvestment Ratio (2007–2014)

This chart tracks Lexaria Bioscience Corp's Capital Reinvestment Ratio across 6 annual periods. Check Lexaria Bioscience Corp investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Lexaria Bioscience Corp (2007–2014)

Year-by-year Capital Reinvestment Ratio for Lexaria Bioscience Corp from 2007 to 2014. For live market cap and broader valuation context, see LEXXW stock market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2014 0.29x $321.00K $91.61K ▲ +0.0%
2013 0.29x $321.00K $91.61K ▲ +0.0%
2012 0.29x $321.00K $91.61K ▼ -85.8%
2011 2.02x $135.94K $274.13K ▼ -77.9%
2010 9.13x $109.84K $1.00 Million ▼ -54.5%
2007 20.06x $29.04K $582.43K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow